Literature DB >> 2448392

Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes.

B L Gruber1, M L Baeza, M J Marchese, V Agnello, A P Kaplan.   

Abstract

The prevalence of autoantibodies of immunoglobulin G (IgG) and immunoglobulin M (IgM) classes directed against myeloma immunoglobulin E (IgE) were determined in distinct subsets of urticaria, using an enzyme immunoassay. IgG anti-IgE antibodies were found in five of nine patients (55%) with cold urticaria, four of eight patients (50%) with urticarial vasculitis, and three of six patients (50%) with chronic urticaria. IgM anti-IgE antibodies were found exclusively in cold urticaria (two of nine patients, 22%). Heating of these sera increased the binding to IgE, suggesting immune complex formation. Several positive sera were capable of inducing histamine release from normal peripheral basophils and caused a wheal-flare response upon intradermal injection. Sera containing such autoantibodies from three cold urticaria patients were studied for passive transfer of cold sensitivity. One serum containing IgG anti-IgE gave a strongly positive transfer test at 5 h but not 48 h, suggesting a pathogenic role for the IgG.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2448392     DOI: 10.1111/1523-1747.ep12462239

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  54 in total

Review 1.  Idiopathic anaphylaxis. The evolution of a disease.

Authors:  R Patterson
Journal:  Clin Rev Allergy Immunol       Date:  1999       Impact factor: 8.667

Review 2.  Activation of blood coagulation in chronic urticaria: pathophysiological and clinical implications.

Authors:  Massimo Cugno; Angelo V Marzano; Riccardo Asero; Alberto Tedeschi
Journal:  Intern Emerg Med       Date:  2009-12-01       Impact factor: 3.397

3.  C5a-induced in vitro basophil activation in patients with chronic urticaria: a pilot study.

Authors:  Peter Korosec; Tjasa Subic; Katja Adamic; Mira Silar; Mitja Kosnik
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

4.  Substance P is upregulated in the serum of patients with chronic spontaneous urticaria.

Authors:  Martin Metz; Clemens Krull; Tomasz Hawro; Rohit Saluja; Adriane Groffik; Christian Stanger; Petra Staubach; Marcus Maurer
Journal:  J Invest Dermatol       Date:  2014-05-20       Impact factor: 8.551

Review 5.  Biologic agents in the treatment of urticaria.

Authors:  Allen P Kaplan
Journal:  Curr Allergy Asthma Rep       Date:  2012-08       Impact factor: 4.806

6.  Autoantibodies in chronic idiopathic urticaria and nonurticarial systemic autoimmune disorders.

Authors:  Christine B Cho; Shahan A Stutes; Michelle L Altrich; Stacy P Ardoin; Gary Phillips; Princess U Ogbogu
Journal:  Ann Allergy Asthma Immunol       Date:  2013-01       Impact factor: 6.347

Review 7.  Autoimmune urticaria.

Authors:  Malcolm Greaves
Journal:  Clin Rev Allergy Immunol       Date:  2002-10       Impact factor: 8.667

Review 8.  Evaluating chronic urticaria patients for allergies, infections, or autoimmune disorders.

Authors:  Y C Wai; Gordon L Sussman
Journal:  Clin Rev Allergy Immunol       Date:  2002-10       Impact factor: 8.667

9.  Progress and challenges in the understanding of chronic urticaria.

Authors:  Marta Ferrer; Allen P Kaplan
Journal:  Allergy Asthma Clin Immunol       Date:  2007-03-15       Impact factor: 3.406

10.  Impact of Desloratadine on Symptoms and Quality of Life in Subjects with Chronic Idiopathic Urticaria: A Multicenter, Practice-based Study.

Authors:  Harold Kim; Charles Lynde
Journal:  Arch Drug Inf       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.